{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:35:42Z","timestamp":1791999342762,"version":"4.4.0"},"reference-count":35,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"unspecified","delay-in-days":70,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ERC","award":["742390"],"award-info":[{"award-number":["742390"]}]},{"name":"DFG, German Research Foundation","award":["493624887"],"award-info":[{"award-number":["493624887"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2025,1,2]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterised by variable treatment responses. We investigated the transcriptional landscape associated with treatment response and resistance in SLE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Blood was collected from 92 active patients with SLE at baseline and after 6\u2009months (n=32 paired samples) of treatment with cyclophosphamide (n=40), rituximab (n=20), belimumab (n=23), mycophenolate mofetil (n=8) or azathioprine (n=1) and was subjected to RNA sequencing. The response was defined by the Lupus Low Disease Activity State. We identified differentially expressed genes and co-expressed transcript modules.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Achieving response, irrespective of treatment, was accompanied by downregulation of B cell immunity-related and complement activation-related signatures. Rituximab led to the most profound decrease in the activity of the B cell pathway, while cyclophosphamide uniquely downregulated neutrophil activation pathways. Responders, regardless of medication, showed increased activity in pathways related to neutrophil migration, type I interferon signalling, complement activation and B cell function prior to treatment. A 539-gene signature, enriched in processes related to chemokine signalling, characterised patients with insufficient response to treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Baseline B cell immunity transcriptional signatures correlate with favourable treatment outcomes\u2014accounting for better responses in serologically active patients in SLE clinical trials\u2014with effective treatment reversing the B cell immunity signature. Cyclophosphamide uniquely targets a neutrophil gene signature linked to severe SLE. Alterations in chemotaxis may represent a mechanism driving resistance to treatment in SLE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2024-005050","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T06:55:12Z","timestamp":1741848912000},"page":"e005050","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosus"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9432-1228","authenticated-orcid":false,"given":"Panagiotis","family":"Garantziotis","sequence":"first","affiliation":[{"name":"Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-Universit\u00e4t (FAU) Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen, Erlangen, Germany"},{"name":"Deutsches Zentrum f\u00fcr Immuntherapie (DZI), FAU Erlangen-N\u00fcrnberg and Universit\u00e4tsklinikum Erlangen, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-9797","authenticated-orcid":false,"given":"Georgia Savina","family":"Moysidou","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemin","family":"Kapsala","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5423-5847","authenticated-orcid":false,"given":"Sofia","family":"Flouda","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysis","family":"Nikolopoulos","sequence":"additional","affiliation":[{"name":"Department of Medicine Solna, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Chavatza","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sentis","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Filia","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Malissovas","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2361-0525","authenticated-orcid":false,"given":"Antigone","family":"Pieta","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece"},{"name":"University General Hospital of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggelos","family":"Banos","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Katechis","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2696-031X","authenticated-orcid":false,"given":"Antonis","family":"Fanouriakis","sequence":"additional","affiliation":[{"name":"4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-1406","authenticated-orcid":false,"given":"George","family":"Bertsias","sequence":"additional","affiliation":[{"name":"Rheumatology, University of Crete School of Medicine, Iraklio, Greece"},{"name":"Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9812-4671","authenticated-orcid":false,"given":"Dimitrios T","family":"Boumpas","sequence":"additional","affiliation":[{"name":"Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece"},{"name":"4th Department of Internal Medicine, National and Kapodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"2025090313073838000_11.1.e005050.1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210382"},{"key":"2025090313073838000_11.1.e005050.2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207347"},{"key":"2025090313073838000_11.1.e005050.3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131137"},{"key":"2025090313073838000_11.1.e005050.4","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000310","article-title":"Changing paradigms in the treatment of systemic lupus erythematosus","volume":"6","author":"Fanouriakis","year":"2019","journal-title":"Lupus Sci Med"},{"key":"2025090313073838000_11.1.e005050.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205139"},{"key":"2025090313073838000_11.1.e005050.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860726","article-title":"Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs","volume":"13","author":"Garantziotis","year":"2022","journal-title":"Front Immunol"},{"key":"2025090313073838000_11.1.e005050.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2022.05.033"},{"key":"2025090313073838000_11.1.e005050.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196"},{"key":"2025090313073838000_11.1.e005050.9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/art.42404","article-title":"Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry-Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus","volume":"75","author":"Carter","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025090313073838000_11.1.e005050.10","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/art.40180","article-title":"Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients","volume":"69","author":"Kubo","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2025090313073838000_11.1.e005050.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2025090313073838000_11.1.e005050.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930"},{"key":"2025090313073838000_11.1.e005050.13","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2025090313073838000_11.1.e005050.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340802"},{"key":"2025090313073838000_11.1.e005050.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207726"},{"key":"2025090313073838000_11.1.e005050.16","unstructured":"Andrews S . FastQC: a quality control tool for high throughput sequence data. 2010. Available: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc"},{"key":"2025090313073838000_11.1.e005050.17","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu638"},{"key":"2025090313073838000_11.1.e005050.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025090313073838000_11.1.e005050.19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm226"},{"key":"2025090313073838000_11.1.e005050.20","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELS.2015.12.004"},{"key":"2025090313073838000_11.1.e005050.21","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2025090313073838000_11.1.e005050.22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab835"},{"key":"2025090313073838000_11.1.e005050.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0114-2"},{"key":"2025090313073838000_11.1.e005050.24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrrheum.2016.18","article-title":"The BAFFling effects of rituximab in lupus: danger ahead?","volume":"12","author":"Ehrenstein","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"2025090313073838000_11.1.e005050.25","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225319"},{"key":"2025090313073838000_11.1.e005050.26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415998","article-title":"Unraveling the Link between Interferon-\u03b1 and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies","volume":"23","author":"Infante","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2025090313073838000_11.1.e005050.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-02177-0","article-title":"The role of baseline BLyS levels and type 1 interferon-inducible gene signature status in determining belimumab response in systemic lupus erythematosus: a post hoc meta-analysis","volume":"22","author":"Wilkinson","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2025090313073838000_11.1.e005050.28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo5840","article-title":"ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus","volume":"8","author":"Manolakou","year":"2022","journal-title":"Sci Adv"},{"key":"2025090313073838000_11.1.e005050.29","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025090313073838000_11.1.e005050.30","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215782"},{"key":"2025090313073838000_11.1.e005050.31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147671","article-title":"NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-\u03b1 production in patients with SLE","volume":"6","author":"Georgakis","year":"2021","journal-title":"JCI Insight"},{"key":"2025090313073838000_11.1.e005050.32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213181"},{"key":"2025090313073838000_11.1.e005050.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.008"},{"key":"2025090313073838000_11.1.e005050.34","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/rheumatology\/keab825","article-title":"CCR2- and CCR5-mediated macrophage infiltration contributes to glomerular endocapillary hypercellularity in antibody-induced lupus nephritis","volume":"61","author":"Zoshima","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313073838000_11.1.e005050.35","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.58"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2024-005050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:07:46Z","timestamp":1756930066000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2024-005050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3,12]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/rmdopen-2024-005050"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2024-005050","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}